# Ruth E. Langley

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ruth-e-langley/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,693 |
| Field | Gastric Cancer Management and Outcomes |
| h-index | 43 |
| i10-index | 90 |
| Last Known Institution | MRC Clinical Trials Unit at UCL |
| OpenAlex ID | https://openalex.org/A5011703751 |
| ORCID iD | https://orcid.org/0000-0002-9706-016X |
| Works | 194 |

## Researcher papers

- [Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial](https://scholariq.org/papers/radiotherapy-to-the-primary-tumour-for-newly-diagnosed-metastatic-prostate/)
- [Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus](https://scholariq.org/papers/common-variants-at-the-mhc-locus-and-at-chromosome-16q24-1-predispose-to-barrett/)

## Researcher topics

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [MRC Clinical Trials Unit at UCL](https://scholariq.org/institutions/mrc-clinical-trials-unit-at-ucl/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.